We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+14.45%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.83B
AUM Growth
-$23.2M
Cap. Flow
-$201M
Cap. Flow %
-10.94%
Top 10 Hldgs %
24.61%
Holding
261
New
14
Increased
25
Reduced
199
Closed
13

Top Buys

Rank Stock Value
1
SRAD icon
Sportradar
SRAD
+$23.7M
2
FOUR icon
Shift4
FOUR
+$22.6M
3
PRGS icon
Progress Software
PRGS
+$9.32M
4
QDEL icon
QuidelOrtho
QDEL
+$7.08M
5
VRDN icon
Viridian Therapeutics
VRDN
+$6.06M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$58.7M
2
WNS
WNS Holdings
WNS
+$46.2M
3
TKO icon
TKO Group
TKO
+$23.8M
4
WLDN icon
Willdan Group
WLDN
+$8.81M
5
EEFT icon
Euronet Worldwide
EEFT
+$7.12M

Sector Composition

Rank Sector Weight
1 Healthcare 32.04%
2 Technology 28.06%
3 Industrials 17.55%
4 Consumer Discretionary 6.84%
5 Communication Services 5.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DORM icon
76
Dorman Products
DORM
$4.07B
$5.87M 0.32%
37,642
-631
-2% -$90.5K
PNTG icon
77
Pennant Group
PNTG
$1.37B
$5.69M 0.31%
225,578
-3,176
-1% -$77.9K
CCSI icon
78
Consensus Cloud Solutions
CCSI
$675M
$5.62M 0.31%
191,333
-18,468
-9% -$458K
BMRN icon
79
BioMarin Pharmaceuticals
BMRN
$12.8B
$5.6M 0.31%
103,425
+97,657
+1,693% +$5.58M
LOB icon
80
Live Oak Bancshares
LOB
$1.95B
$5.54M 0.3%
157,321
+9,088
+6% +$313K
OR icon
81
OR Royalties Inc
OR
$6.25B
$5.28M 0.29%
131,740
-16,874
-11% -$527K
EHC icon
82
Encompass Health
EHC
$12.4B
$5.2M 0.28%
40,943
-313
-0.8% -$37.3K
MIR icon
83
Mirion Technologies
MIR
$3.73B
$5.19M 0.28%
223,031
-46,792
-17% -$1.01M
URGN icon
84
UroGen Pharma
URGN
$2.28B
$5.17M 0.28%
259,143
-28,731
-10% -$516K
AAOI icon
85
Applied Optoelectronics
AAOI
$11.3B
$5.17M 0.28%
199,193
-39,741
-17% -$1.02M
RMBS icon
86
Rambus
RMBS
$10.7B
$5.08M 0.28%
48,779
-20,007
-29% -$1.54M
GO icon
87
Grocery Outlet
GO
$958M
$5.07M 0.28%
315,898
+196,737
+165% +$3.14M
GRBK icon
88
Green Brick Partners
GRBK
$3.02B
$5.05M 0.28%
68,416
-18,591
-21% -$1.27M
ATEN icon
89
A10 Networks
ATEN
$2.06B
$4.97M 0.27%
273,797
-64,268
-19% -$1.16M
GPGI
90
GPGI Inc
GPGI
$4.17B
$4.96M 0.27%
237,997
-26,929
-10% -$466K
VRNA
91
DELISTED
Verona Pharma
VRNA
$4.88M 0.27%
45,748
-562,248
-92% -$58.7M
SSTI icon
92
SoundThinking
SSTI
$104M
$4.85M 0.26%
402,441
-44,564
-10% -$553K
ADMA icon
93
ADMA Biologics
ADMA
$2.22B
$4.74M 0.26%
323,653
-66,962
-17% -$1.15M
DY icon
94
Dycom Industries
DY
$12.2B
$4.63M 0.25%
15,858
-116
-0.7% -$30.4K
KTOS icon
95
Kratos Defense & Security Solutions
KTOS
$11.7B
$4.53M 0.25%
49,570
-39,963
-45% -$2.56M
PL icon
96
Planet Labs
PL
$8.45B
$4.39M 0.24%
+338,349
New +$2.61M
VCYT icon
97
Veracyte
VCYT
$3.73B
$4.37M 0.24%
127,259
-1,034
-0.8% -$29.7K
GXO icon
98
GXO Logistics
GXO
$5.45B
$4.27M 0.23%
80,823
-7,651
-9% -$393K
SWIM icon
99
Latham Group
SWIM
$841M
$4.26M 0.23%
559,590
-22,533
-4% -$166K
GATX icon
100
GATX Corp
GATX
$6.24B
$4.23M 0.23%
24,227
-190
-0.8% -$30.7K
2 3
4
5 6

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q3 2025 Portfolio in Review

As of Q3 2025, Rice Hall James & Associates held 261 positions worth $1.83B, down 1.2% from $1.86B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $201M in Q3 2025, closing 13 positions and reducing 199 holdings. Its most notable exit was Olo Inc, an estimated $4.38M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Sportradar worth $21.5M.

  • Rice Hall James & Associates's largest Q3 2025 buy was Sportradar: 799,217 shares worth $21.5M.
  • Rice Hall James & Associates added most to Shift4 in Q3 2025, an estimated $22.6M increase.
  • Rice Hall James & Associates's biggest Q3 2025 reduction was Verona Pharma, cutting an estimated $58.7M.
  • Rice Hall James & Associates fully exited Olo Inc in Q3 2025, selling an estimated $4.38M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $1.83B portfolio in Q3 2025.
  • Rice Hall James & Associates opened 14 new positions and closed 13 in Q3 2025.
  • Rice Hall James & Associates's portfolio value fell 1.2% quarter-over-quarter to $1.83B.

Based on Rice Hall James & Associates's 13F filing for Q3 2025, filed 16 Oct 2025.